Track 21: HIV gene therapy

In patients with HIV, highly active antiretroviral therapy significantly increases survival. The existence of drug-resistant escape mutations, cumulative toxicities, and partial immunological recovery can make lifelong treatment more difficult as a result of the persistence of HIV in reservoirs. In the absence of long-term antiviral medication, cell and gene therapies hold the potential of avoiding progressive HIV infection by blocking HIV replication.


    Related Conference of Track 21: HIV gene therapy

    July 21-22, 2025

    18th World Congress on Stem Cell Research

    Barcelona, Spain
    August 28-29, 2025

    12th World Congress on Epigenetics and Chromosome

    London, UK
    September 16-17, 2025

    5th Experts Meeting on Plant, Cellular and Molecular Biology

    Madrid, Spain
    September 25-26, 2025

    18th World Congress on Advances in Stem Cell Research and Regenerative Medicine

    Montreal, Canada
    October 27-28, 2025

    20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research

    Madrid, Spain
    October 30-31, 2025

    Annual Congress on CRISPR Cas9 Technology and Genetic Engineering

    Rome, Italy
    November 17-18, 2025

    18th International Conference on Human Genomics and Genomic Medicine

    Paris, France
    June 18-19, 2026

    16th International Conference on Human Genetics and Genetic Diseases

    Singapore City, Singapore
    June 18-19, 2026

    19th International Conference on Genomics & Pharmacogenomics

    Singapore City, Singapore
    September 25-26, 2025

    6th Annual summit on Cell Signaling and Cancer Therapy

    Montreal, Canada

    Track 21: HIV gene therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in